Clinical Trial Update: A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of TAK-755 (recombinant ADAMTS13) evaluating reduced plasma exchange in adults with immune-mediated thrombotic thrombocytopenic pu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombotic Thrombocytopenic Purpura

Drugs mentioned

• TAK-755

Snippet

Sponsor: Takeda | Conditions: Thrombotic Thrombocytopenic Purpura (TTP) | Phase 2 | Status: ACTIVE_NOT_RECRUITING